Exelixis Inc Increase (Decrease) in Deferred Revenue
Exelixis Inc (EXEL) reported Increase (Decrease) in Deferred Revenue of $5.91 million for the 6-month period ending 2018-06-29, per its 10-Q filed 2018-08-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-08-01
- Exelixis Inc increase (decrease) in deferred revenue for the quarter ending 2018-06-29 was $8.56M.
- Exelixis Inc increase (decrease) in deferred revenue for the quarter ending 2018-03-30 was -$2.65M, a 107.55% decline year-over-year.
- Exelixis Inc increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$7.45M, a 113.29% decline year-over-year.
- Exelixis Inc increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$6.98M.
- Exelixis Inc increase (decrease) in deferred revenue for fiscal 2017 was $13.74M, a 94.65% decline from fiscal 2016.
- Exelixis Inc increase (decrease) in deferred revenue for fiscal 2016 was $256.76M.
- Exelixis Inc increase (decrease) in deferred revenue for fiscal 2016 was $256.76M.
- Exelixis Inc increase (decrease) in deferred revenue for fiscal 2016 was -$2.58M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-06-29 | $8.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $5.91M 10-Q · filed 2018-08-01 | ||
| 2018-03-30 | -$2.65M 10-Q · filed 2018-05-02 | |||
| 2017-12-29 | $13.74M 10-K · filed 2018-02-26 | |||
| 2017-09-30 | -$7.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$14.43M derived: sum of 2 quarters · filed 2017-11-01 | $20.71M 10-Q · filed 2017-11-01 | $25.96M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-06-30 | -$6.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $28.16M 10-Q · filed 2017-08-02 | $33.41M derived: sum of 3 quarters · filed 2018-05-02 | $89.45M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-03-31 | $35.14M 10-Q · filed 2017-05-01 | $40.39M derived: sum of 2 quarters · filed 2018-05-02 | $96.43M derived: sum of 3 quarters · filed 2018-05-02 | $93.10M derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $61.29M derived: sum of 2 quarters · filed 2017-11-01 | $57.96M derived: sum of 3 quarters · filed 2017-11-01 | $256.76M 10-K · filed 2017-02-27 |
| 2016-12-30 | $256.76M 10-K · filed 2018-02-26 | |||
| 2016-09-30 | $56.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $52.71M derived: sum of 2 quarters · filed 2017-11-01 | $251.51M 10-Q · filed 2017-11-01 | $251.51M derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-06-30 | -$3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $195.47M 10-Q · filed 2017-08-02 | $195.47M derived: sum of 3 quarters · filed 2017-08-02 | $195.47M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | $198.80M 10-Q · filed 2017-05-01 | $198.80M derived: sum of 2 quarters · filed 2017-05-01 | $198.80M derived: sum of 3 quarters · filed 2017-05-01 | $198.80M derived: sum of 4 quarters · filed 2017-05-01 |
| 2016-01-01 | -$2.58M 10-K · filed 2018-02-26 | |||
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.00K derived: sum of 2 quarters · filed 2017-02-27 | -$6.00K derived: sum of 3 quarters · filed 2017-02-27 | -$2.58M 10-K · filed 2017-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$7.00K derived: sum of 2 quarters · filed 2016-11-03 | -$2.58M 10-Q · filed 2016-11-03 | -$1.32M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$2.58M 10-Q · filed 2016-08-03 | -$1.32M derived: sum of 3 quarters · filed 2017-02-27 | -$1.13M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | -$2.58M 10-Q · filed 2016-05-04 | -$1.31M derived: sum of 2 quarters · filed 2017-02-27 | -$1.12M derived: sum of 3 quarters · filed 2017-02-27 | -$1.24M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.46M derived: sum of 2 quarters · filed 2017-02-27 | $1.34M derived: sum of 3 quarters · filed 2017-02-27 | $1.13M 10-K · filed 2017-02-27 |
| 2014-09-30 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $76.00K derived: sum of 2 quarters · filed 2015-11-10 | -$131.00K 10-Q · filed 2015-11-10 | $302.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$323.00K 10-Q · filed 2015-08-11 | $110.00K derived: sum of 3 quarters · filed 2016-02-29 | -$380.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$207.00K 10-Q · filed 2015-04-30 | $226.00K derived: sum of 2 quarters · filed 2016-02-29 | -$264.00K derived: sum of 3 quarters · filed 2016-02-29 | -$7.97M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$57.00K derived: sum of 2 quarters · filed 2016-02-29 | -$7.76M derived: sum of 3 quarters · filed 2016-02-29 | -$14.87M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$490.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$8.19M derived: sum of 2 quarters · filed 2014-11-04 | -$15.30M 10-Q · filed 2014-11-04 | -$23.12M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$14.81M 10-Q · filed 2014-07-31 | -$22.63M derived: sum of 3 quarters · filed 2015-03-02 | -$30.44M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | -$7.11M 10-Q · filed 2014-05-01 | -$14.92M derived: sum of 2 quarters · filed 2015-03-02 | -$22.74M derived: sum of 3 quarters · filed 2015-03-02 | -$30.55M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$15.63M derived: sum of 2 quarters · filed 2015-03-02 | -$23.44M derived: sum of 3 quarters · filed 2015-03-02 | -$41.92M 10-K · filed 2015-03-02 |
| 2012-09-30 | -$7.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$15.63M derived: sum of 2 quarters · filed 2013-10-30 | -$34.11M 10-Q · filed 2013-10-30 | -$103.47M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | -$7.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$26.29M 10-Q · filed 2013-08-06 | -$95.66M derived: sum of 3 quarters · filed 2014-02-20 | -$220.32M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | -$18.48M 10-Q · filed 2013-05-07 | -$87.85M derived: sum of 2 quarters · filed 2014-02-20 | -$212.51M derived: sum of 3 quarters · filed 2014-02-20 | -$237.61M derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | -$69.37M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$194.03M derived: sum of 2 quarters · filed 2014-02-20 | -$219.13M derived: sum of 3 quarters · filed 2014-02-20 | -$244.53M 10-K · filed 2014-02-20 |
| 2011-09-30 | -$124.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$149.76M derived: sum of 2 quarters · filed 2012-11-07 | -$175.16M 10-Q · filed 2012-11-07 | -$139.91M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | -$25.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$50.50M 10-Q · filed 2012-08-02 | -$15.24M derived: sum of 3 quarters · filed 2013-02-21 | -$58.15M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | -$25.40M 10-Q · filed 2012-05-03 | $9.86M derived: sum of 2 quarters · filed 2013-02-21 | -$33.05M derived: sum of 3 quarters · filed 2013-02-21 | |
| 2010-12-31 | $35.26M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$7.66M derived: sum of 2 quarters · filed 2013-02-21 | -$42.95M 10-K · filed 2013-02-21 | |
| 2010-09-30 | -$42.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$78.20M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | -$35.29M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $85.78M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |